- Home
- ONMD vs PYPD Comparison
ONMD vs PYPD Comparison
Compare ONMD & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONMD
- PYPD
- Stock Information
- Founded
- ONMD 2006
- PYPD 2008
- Country
- ONMD United States
- PYPD Israel
- Employees
- ONMD N/A
- PYPD N/A
- Industry
- ONMD
- PYPD Medical/Dental Instruments
- Sector
- ONMD
- PYPD Health Care
- Exchange
- ONMD Nasdaq
- PYPD Nasdaq
- Market Cap
- ONMD 32.5M
- PYPD 30.1M
- IPO Year
- ONMD N/A
- PYPD 2020
- Fundamental
- Price
- ONMD $0.70
- PYPD $2.94
- Analyst Decision
- ONMD
- PYPD Strong Buy
- Analyst Count
- ONMD 0
- PYPD 2
- Target Price
- ONMD N/A
- PYPD $10.50
- AVG Volume (30 Days)
- ONMD 51.1K
- PYPD 14.2K
- Earning Date
- ONMD 12-17-2024
- PYPD 05-07-2025
- Dividend Yield
- ONMD N/A
- PYPD N/A
- EPS Growth
- ONMD N/A
- PYPD N/A
- EPS
- ONMD 0.01
- PYPD N/A
- Revenue
- ONMD $957,651.00
- PYPD N/A
- Revenue This Year
- ONMD N/A
- PYPD N/A
- Revenue Next Year
- ONMD N/A
- PYPD $4,820.00
- P/E Ratio
- ONMD $87.64
- PYPD N/A
- Revenue Growth
- ONMD 1.36
- PYPD N/A
- 52 Week Low
- ONMD $0.46
- PYPD $2.37
- 52 Week High
- ONMD $3.37
- PYPD $5.50
- Technical
- Relative Strength Index (RSI)
- ONMD 33.54
- PYPD 49.66
- Support Level
- ONMD $0.57
- PYPD $2.82
- Resistance Level
- ONMD $0.77
- PYPD $3.20
- Average True Range (ATR)
- ONMD 0.09
- PYPD 0.22
- MACD
- ONMD -0.01
- PYPD -0.00
- Stochastic Oscillator
- ONMD 27.08
- PYPD 38.46
About ONMD OneMedNet Corp
OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a global provider of clinical imaging innovation and curator of regulatory-grade Imaging Real-World Data or iRWDTM. OneMedNet's innovative solutions connect healthcare providers and patients satisfying a crucial need within the Life Sciences field offering direct access to clinical images and the associated contextual patient record.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.